Population pharmacokinetic and pharmacogenetics of imatinib in Chinese patients with chronic myeloid leukemia
{{output}}
Aim: This study aimed to establish a population pharmacokinetic (PPK) model in Chinese patients with chronic myeloid leukemia, and to quantify the effects of pharmacogenetics on pharmacokinetic parameters of imatinib. ... ...
